MedCap AB (publ)
STO:MCAP
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
296
609
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MCAP stock under the Base Case scenario is 426.82 SEK. Compared to the current market price of 575 SEK, MedCap AB (publ) is Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
MedCap AB (publ)
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MCAP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
MedCap AB (publ)
Balance Sheet Decomposition
MedCap AB (publ)
Current Assets | 873.7m |
Cash & Short-Term Investments | 287.7m |
Receivables | 319.1m |
Other Current Assets | 266.9m |
Non-Current Assets | 1B |
Long-Term Investments | 500k |
PP&E | 382.6m |
Intangibles | 630.7m |
Other Non-Current Assets | 6.6m |
Current Liabilities | 331.9m |
Accounts Payable | 238.6m |
Other Current Liabilities | 93.3m |
Non-Current Liabilities | 369m |
Long-Term Debt | 296.1m |
Other Non-Current Liabilities | 72.9m |
Earnings Waterfall
MedCap AB (publ)
Revenue
|
1.8B
SEK
|
Cost of Revenue
|
-954.9m
SEK
|
Gross Profit
|
834.2m
SEK
|
Operating Expenses
|
-539.9m
SEK
|
Operating Income
|
294.3m
SEK
|
Other Expenses
|
-66.4m
SEK
|
Net Income
|
227.9m
SEK
|
Free Cash Flow Analysis
MedCap AB (publ)
SEK | |
Free Cash Flow | SEK |
MCAP Profitability Score
Profitability Due Diligence
MedCap AB (publ)'s profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
MedCap AB (publ)'s profitability score is 62/100. The higher the profitability score, the more profitable the company is.
MCAP Solvency Score
Solvency Due Diligence
MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MCAP Price Targets Summary
MedCap AB (publ)
Dividends
Current shareholder yield for MCAP is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Officers
The intrinsic value of one MCAP stock under the Base Case scenario is 426.82 SEK.
Compared to the current market price of 575 SEK, MedCap AB (publ) is Overvalued by 26%.